In response to the global spread of antimicrobial resistance, there is an increased demand
for novel and innovative antimicrobials. Bacteriophages have been known for their potential …

Increasing reports of antimicrobial resistance and limited new antibiotic discoveries and
development have fuelled innovation in other research fields and led to a revitalization of …

In an era of proliferating multidrug resistant bacterial infections that are exhausting the
capacity of existing chemical antibiotics and in which the development of new antibiotics is …

Burgeoning problems of antimicrobial resistance dictate that new solutions be developed to
combat old foes. Use of lytic bacteriophages (phages) for the treatment of drug-resistant …

Use of bacterial viruses as antibacterial agents has a history nearly as long as the now 100-
year study of bacteriophages. Therapeutic phages are especially useful in the absence of …

Approximately 10% of global health research is devoted to 90% of global disease burden
(the so-called “10/90 Gap”) and it often neglects those diseases most prevalent in low …

Antibiotic resistance is arguably the biggest current threat to global health. An increasing
number of infections are becoming harder or almost impossible to treat, carrying high …

Antimicrobial resistance is increasing despite new treatments being employed. With a
decrease in the discovery rate of novel antibiotics, this threatens to take humankind back to …

In times where only a few novel antibiotics are to be expected, antimicrobial resistance
remains an expanding global health threat. In case of chronic infections caused by therapy …

Antibiotic resistance in bacterial pathogens presents a substantial threat to the control of
infectious diseases. Development of new classes of antibiotics has slowed in recent years …